Cysticercosis and epilepsy: A critical review

Epilepsia

Volumn 39, Issue 10, 1998, Pages 1025-1040

  Carpio, Arturo ^a,d   Escobar, Alfonso ^b   Hauser, W Allen ^c  

^a UNIVERSIDAD DE CUENCA   (Ecuador)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^c Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^d NONE   (Ecuador)

Author keywords

Antihelminthic treatment; Cysticercosis; Epidemiology; Epilepsy; Imaging studies

Indexed keywords

CYSTICERCOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; EPILEPTOGENESIS; HOST PARASITE INTERACTION; HUMAN; INFECTION RISK; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TAENIA SOLIUM;

ALBENDAZOLE; ANTHELMINTICS; ANTIPLATYHELMINTIC AGENTS; BRAIN; BRAIN DISEASES; CLINICAL TRIALS; COMORBIDITY; CYSTICERCOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPILEPSY; HUMANS; MAGNETIC RESONANCE IMAGING; PRAZIQUANTEL; PREVALENCE; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031717251     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1998.tb01287.x     Document Type: Review

References (201)

1. Schantz PM, Moore AC, Muñoz JL, et al. Neurocysticercosis in an orthodox Jewish community in New York City. N Engl J Med 1992;327:692-5.
2. Schantz PM. Cysticercosis in non-endemic countries: the example of the United States. In: Garcia HH, Martínez S, eds. Teniasis/cisticercosis por T. solium. Lima: Editorial Universo S.A., 1996:277-86.
3. Preux PM, Melaku Z, Druet-Cabanac M, et al. Cysticercosis and neurocysticercosis in Africa: current status. Neurol Infect Epidemiol 1996;1:63-8.
4. Carpio A. Cisticercosis cerebral: enfermedad del subdesarrollo. Cuenca: Facultad de Ciencias Medicas de la Universidad de Cuenca, 1985.
5. Sarti E, Schantz PM, Plancaarte A, et al. Prevalence and risk factors for Taenia solium taeniasis and cysticercosis in humans and pigs in a village in Morelos, México. Am J Trop Med Hyg 1992;46:677-85.
6. Carpio A, Santillán F, León P. Aspectos clinicos de la cisticercosis. Rev Inst Inv Cienc Salud (Ecuador) 1990;5:1-40.
7. McCormick GF, Zee CS, Heiden J. Cysticercosis cerebri. Arch Neurol 1982;39:534-9.
8. Faust EC, Russell PF, Jung RC. Cysticercosis. In: Faust EC, ed. Clinical parasitology. Philadelphia: Lea & Febiger, 1979:529-35.
9. Escobar A, Nieto D. Cysticercosis. In: Minkler J, ed. The pathology of the nervous system. New York: McGraw-Hill, 1972:2507-15.
10. Evans C. The immunology of taeniasis/cysticercosis: implications for prevention and treatment. In: Garcia HH, Martínez S, eds. Teniasis/cisticercosis por T. solium. Lima: Editorial Universo S.A., 1996:50-64.
11. Flisser A, Willms K, Laclette JP, et al. Cysticercosis. Present state of knowledge and perspectives. New York: Academic Press, 1982.
12. Correa D, Dalma D, Espinoza B, et al. Heterogeneity of humoral immune components in human cysticercosis. J Parasitol 1985; 71:535-41.
13. Goodman K, Carpio A, Ballagh SA. Case-control study of seropositivity for cysticercosis in Cuenca, Ecuador. J Neurol Sci 1997;150:S326.
14. Spina-Franca A, Livramento JA, Bacheschi LA, Garcia-Lopez P. Cerebrospinal fluid immunoglobulins in cysticercosis of the central nervous system. Arq Neuropsiquiatr 1976;34:40-5.
15. Carpio A. Epidemiology of tropical neurology in South America. In: Rose FC, ed. Recent advances in tropical neurology. Amsterdam: Elsevier Sciences Publishers, 1995:31-42.
16. Carpio A. La neurocisticercosis en el Ecuador. In: Benitez R, Ordoñez G, eds. Biopatología Andina y Tropical Ecuatoriana, Tomo III. Quito: Academia Ecuatoriana de Medicina, 1995:1383-410.
17. García-Albea EE. Cisticercosis cerebral: Aportaciones al conocimiento de una enfermedad endémica en España e Hispanoamérica. Madrid: Aran Ediciones S.A., 1991.
18. García-Ramos G, Rubio-Donnadieu F. Neurocysticercosis in the adult. In: Palacios E, Rodriguez-Carbajal J, Taveras JM, eds. Cysticercosis of central nervous system. Springfield: Charles C Thomas, 1983:63-8.
19. Singhal BS, Ladiwala U. Neurocysticercosis in India. In: Rose FC, ed. Recent advances in tropical neurology. Amsterdam: Elsevier Sciences Publishers, 1995:31-42.
20. Bittencourt PRM, Costa AJ, Oliveira TV, et al. Clinical, radiological and cerebrospinal fluid presentation of neurocysticercosis: a prospective study. Arq Neuropsiquiatr (Sao Paulo) 1990;48: 286-95.
21. Bittencourt PRM, Adamolekun B, Bharucha N, et al. Epilepsy in the tropics: II. Clinical presentations, pathophysiology, immunologic diagnosis, economics and therapy. Epilepsia 1996;37: 1121-7.
22. Mervis B, Lotz JW. Computed tomography (CT) in parenchymatous cerebral cysticercosis. Clin Radiol 1980;31:521-8.
23. Byrd SE, Locke GE, Biggers S, Percy AK. The computed tomography appearance of cerebral cysticercosis in adults and children. Radiology 1982;144:819-23.
24. Enzman DR. Imaging of infections and inflammations of the central nervous system. New York: Raven Press, 1984:102-27.
25. Handler LC, Mervis B. Cerebral cysticercosis with reference to the natural history of parenchymal lesions. AJNR 1983;4:709-12.
26. Rodriguéz-Carbajal J, Palacios G, Zeen Ch. Neuroradiology of the cysticercosis of the central nervous system. In: Palacíos J, Rodriguéz Carbajal J, Taveras J, eds. Cysticercosis of the central nervous system. Springfield: Charles C. Thomas, 1983:101-43.
27. Suss RA, Maravilla KR, Thompson J. MR imaging of intracranial cysticercosis: comparison with CT and anatomopathologic features. AJNK 1986;7:235-42.
28. Martinez HR, Rangel-Guerra R, Elizondo G, et al. MR imaging in neurocysticercosis: a study of 56 cases. AJNR 1989;10:1011-9.
29. Carpio A, Placencia M, Santillán F, Escobar A. Proposal for a new classification of neurocysticercosis. Can J Neurol Sci 1994; 21:43-7.
30. Carpio A. Clasificación de la neurocisticercosis. In: Garcia HH, Martínez S, eds. Teniasis/cisticercosis por T. solium. Lima: Editorial Universo S.A., 1996:139-52.
31. Arriagada C, Matus C, Nogales-Gaete J. Tomografia computada en neurocisticercosis. In: Arriagada C, Nogales-Gaete J, Apt W, eds. Neurocisticercosis. Aspectos epidemiológicos, patológicos, inmunológicos, clínicos, imagenológicos y terapéuticos. Santiago-Chile: Arrynog Ediciones, 1997:161-207.
32. Paez R. Neuroimagen: texto de docencia medica. Quito: Color-Offset, 1997.
33. Dumas JL, Visy JM, Belin C, Gaston A, Goldlust D, Dumas M. Parenchymal neurocysticercosis: follow-up and staging by MRI, Neuroradiology 1997;39:12-8.
34. Allan JC, Mencos F, Garcia-Noval J, et al. Dipstick dot-ELISA for detection of Taenia coproantigens in humans. Parasitology 1993;107:79-85.
35. Schenone H, Villarroel F, Rojas A, Ramírez R. Epidemiology of human cysticercosis in Latin America. In: Flisser A, Willms K, Laclette JP, et al. Cysticercosis: present state of knowledge and perspectives. New York: Academic Press, 1982:25-38.
36. Díaz F, García HH, Gilman RH, et al. Epidemiology of taeniasis and cysticercosis in a Peruvian village. Am J Epidemiol 1992; 135:875-82.
37. Ramos-Kuri M, Montoya RM, Padilla A, et al. Immunodiagnosis of neurocysticercosis: disappointing performance of serology (enzyme-linked immunosorbent assay) in an unbiased sample of neurological patients. Arch Neurol 1992;49:633-6.
38. Palacios R, Alvarado M, Carpio A, Santillán F, Palacios M. Valoración de las técnicas immunológicas en el diagnóstico de la cisticercosis cerebral. Rev Inst Inv Cienc Salud (Ecuador). 1988; 3:1-19.
39. Nieto D. Cysticercosis of the nervous system: diagnosis by means of the spinal fluid complement fixation. Neurology 1956;6:725-38.
40. Tsang VC, Brand JA, Boyer AE. An enzyme-linked immunoelectrotransfer blot assay and glycoproteins antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 1989;159:50-9.
41. Tsang VC, Garcia HH. Immunoblot diagnostic test (EITB) for Taenia solium cysticercosis and its contribution to the definition of this under-recognized but serious public health problem. In: Garcia HH, Martínez S, eds. Teniasis/cisticercosis por T. solium. Lima: Editorial Universo S.A., 1996:259-68.
42. Wilson M, Gryan R, Fried J, et al. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 1991;164:1007-9.
43. García HH, Martínez M, Gilman R, et al. Diagnosis of cysticercosis in endemic regions. Lancet 1991;338:549-51.
44. García HH, Gilman R, Martínez M, Tsang VCW. Cysticercosis as a major cause of epilepsy in Peru. Lancet 1993;341:197-200.
45. Moore AC, Lutwick LI, Schantz PM, et al. Seroprevalence of cysticercosis in an orthodox Jewish community. Am J Trop Med 1995;53:439-42.
46. Cruz I, Epidemiologia de la neurocisticercosis en el Ecuador. In: Garcia HH, Martínez S, eds. Teniasis/cisticercosis por T. solium. Lima: Editorial Universo S.A., 1996:303-11.
47. Palacio LG, Tobón M, Sanchez JL, Jiménes M, Jiménes I. Prevalencia de neurocisticercosis en individuos con epilepsia en Medellín, Colombia. In: Garcia HH, Martínez S, eds. Teniasis/ cisticercosis por T. solium. Lima: Editorial Universo S.A., 1996: 291-302.
48. Grill J, Rakotomalala W, Andriantsimahavandy A, et al. High prevalence of serological markers of cysticercosis among epileptic Malagasy children. Ann Trop Paediatr 1996;16:185-91.
49. García HH, Gilman RH, Tsang VC, Gonzalez AE. Clinical significance of neurocysticercosis in endemic villages: The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg 1997;91:176-8.
50. Garcia-Noval J, Allan JC, Fletes C, et al. Epidemiology of Taenia solium taeniasis and cysticercosis in two rural Guatemalan communities. Am J Trop Med Hyg 1996;55:282-9.
51. Schantz PM, Sarti E, Plancarte A, et al. Community-based epidemiological investigations of cysticercosis due to Taenia solium: comparison of serological screening tests and clinical findings in two populations in México. Clin Infect Dis 1994;18: 879-85.
52. García HH, Herrera G, Gilman RH, et al. Discrepancies between cerebral computed tomography and Western blot in the diagnosis of neurocysticercosis. Am J Trop Med Hyg 1994;50:152-6.
53. Cruz ME, Davis A, Dixon H, Pawlowski ZS, Proaño J. Operational studies on the control of Taenia solium taeniasis/cysticercosis in Ecuador. Bull WHO 1989;67:401-7.
54. Keilbach NM, de Aluja AS, Sarti-Gutierrez E. A program to control taeniasis-cysticercosis (T. solium): experiences in a Mexican village. Acta Leiden 1989;57:181-9.
55. Diaz-Camacho SP, Candil-Ruiz A, Suate V, et al. Epidemiologic study and control of Taenia solium infections with praziquantel in a rural village of Mexico. Am J Trop Med Hyg 1991;45:522-31.
56. Gilman RH, Garcia HH, Gonzales AE, et al. Métodos para controlar la transmisión de la cisticercosis. In: Garcia HH, Martínez S. eds. Teniasis/cisticercosis por T. solium. Lima: Editorial Universo S.A., 1996:327-39.
57. Carpio A, Placencia M. Definition of contemporary surgical management in cisternal and parenchymatous cysticercosis cerebri. Neurosurgery 1992;30:968-9.
58. Kramer LD, Locke GE, Byrd SE, Daryabagi J. Cerebral cysticercosis: documentation of natural history with CT. Radiology 1989; 171:459-62.
59. Machado LR, Nobrega JP, Barros NG, Livramento JA, Bacheschi LA, Spina-Franca A. Computed tomography in neurocysticercosis: a 10-year long evolution analysis of 100 patients with an appraisal of a new classification. Arq Neuropsiquiatr (Sao Paulo) 1990;48:414-8.
60. Martinez HR, Rangel-Guerra R, Arredondo-Estrada JH, Marfil A, Onofre J. Medical and surgical treatment in neurocysticercosis: a magnetic resonance study of 161 cases. J Neurol Sci 1995;130: 25-34.
61. Miller B, Grinnell V, Goldberg MA, et al. Spontaneous radiographic disappearance of cerebral cysticercosis: three cases. Neurology 1983;33:1377-9.
62. Cuetter AC, Garcia-Bobadilla J, Guerra LG, Martinez FM, Kaim B. Neurocysticercosis: focus on intraventricular disease. Clin Infect Dis 1997;24:157-64.
63. Rajshekhar V. Etiology and management of single small CT lesions in patients with seizures: understanding a controversy. Acta Neurol Scand 1991;84:465-70.
64. Rajshekhar V, Chandy MJ. Comparative study of CT and MRI in patients with seizures and a solitary cerebral cysticercus granuloma. Neuroradiology 1996;38:542-6.
65. Rodiguez-Carbajal J, Salgado P, Gutierrez-Alvarado R, Escobar-Izquierdo A, Aruffo C, Palacios E. The acute encephalitic phase of neurocysticercosis: computed tomographic manifestations. AJNR 1983;4:51-5.
66. Zee CS, Segall HD, Destian S, Ahmadi J, Apuzzo MLJ. MRI of intraventricular cysticercosis: surgical implications. J Comput Assist Tomogr 1993;17:932-9.
67. Teitelbaum GP, Otto RJ, Watanabe AT, et al. MR imaging of neurocysticercosis. AJNR 1989;10:709-18.
68. Mitchel WG, Snodgrass SR. Intraparenchymal cerebral cysticercosis in children: a benign prognosis. Pediatr Neurol 1985;1: 151-6.
69. Mazer S, Antoniuk A, Ditzel LFS, Araujo JC. The computed tomographic spectrum of cerebral cysticercosis. Comput Radiol 1983;7:373-8.
70. Lotz J, Hewlett R, Alheit B, Bowen R. Neurocysticercosis: correlative pathomorphology and MR imaging. Neuroradiology 1988;30:35-41.
71. Arriagada V, Arriagada C, Terra E, Manen R, Julio D. Imagen de resonancia magnética en neurocisticercosis. In: Arriagada C, Nogales-Gaete J, Apt W, eds. Neurocisticercosis: aspectos epidemiológicos, patológicos, inmunológicos, clínicos, imagenológicos y terapéuticos. Santiago, Chile: Arrynog Ediciones, 1997: 209-78.
72. Escobar A. The pathology of neurocysticercosis. In: Palacios E, Rodriguez-Carbajal J, Taveras JM, eds. Cysticercosis of central nervous system. Springfield: Charles C Thomas, 1983:27-54.
73. Trelles JO, Trelles L. Cysticercosis of the nervous system. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology. Amsterdam: North-Holland, 1978:291-320.
74. Wadia NS, Desai S, Bhatt M. Disseminated cysticercosis: new observations, including CT scan findings and experience with treatment by praziquantel. Brain 1988;111:507-614.
75. Mitchel WG, Crawford TO. Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment. Pediatrics 1988;82: 76-82.
76. Rodriguéz-Carbajal J, Placencia M, Carpio A. Calcificaciones intracraneales anormales: 135 casos estudiados por T.A.C. Neurol Neurocir Psiquiatr 1983;24:49-60.
77. Sotelo J, Guerrero J, Rubio F. A new classification based on active and inactive forms. Arch Intent Med 1988;148:442-5.
78. Stepien L. Cerebral cysticercosis in Poland: clinical symptoms and operative results in 132 cases. J Neurosurg 1962;19:505-13.
79. Rangel R, Torres B, Del Brutto O, et al. Cysticercotic encephalitis: a severe form in young females. Am J Trop Med Hyg 1987; 36:387-92.
80. Noboa C. Encefalitis cisticercosa: análisis de 10 casos. Rev Ecuat Neurol 1992;1:61-71.
81. López-Hernández A, Garaizar C. Manifestations of infantile cerebral cysticercosis. In: Palacios E. Rodriguez-Carbajal J, Taveras JM, eds. Cysticercosis of central nervous system. Springfield: Charles C Thomas, 1983:69-83.
82. Madrazo I, García-Renteria JA, Sandoval M, Lopez-Vega FJ. Intraventricular cysticercosis. Neurosurgery 1983;12:148-52.
83. Salazar A, Sotelo J, Martinez H, Escobedo F. Differential diagnosis between ventriculitis and fourth ventricle cyst in neurocysticercosis. J Neurosurg 1983;59:660-3.
84. Apuzzo MLJ, Dobkin WR, Zee C-S, et al. Surgical considerations in treatment of intraventricular cysticercosis: an analysis of 45 cases. J Neurosurg 1984;60:400-7.
85. Kioumehr F, Dadsetan MR, Feldman N, et al. Postcontrast MRI of cranial meninges: leptomeningitis versus pachymeningitis. J Comput Assist Tomogr 1995;19:713-20.
86. Alarcón F, Hidalgo F, Moncayo J, Viñán I, Dueñas G. Cerebral cysticercosis and stroke. Stroke 1992;23:224-8.
87. Alarcón F, Vanormeligen K, Moncayo J, Viñán I. Cerebral cysticercosis as a risk factor for stroke in young and middle-aged people. Stroke 1992;23:1563-5.
88. Cantú C, Barinagarrementeria F. Cerebrovascular complications of neurocysticercosis: clinical and neuroimaging spectrum. Arch Neurol 1996;53:233-9.
89. Barinagarrementeria F, Cantú C. Arteritis cerebral cisticercosa. In: Arriagada C, Nogales-Gaete, Apt W, eds. Neurocisticercosis: aspectos epidemiológicos, patológicos, inmunológicos, clínicos, imagenológicos y terapéuticos. Santiago-Chile: Arrynog Ediciones, 1997:139-52.
90. Carpio A, Ochoa M, Bustamante J, et al. Meningitis crónica: estudio clínico de 47 casos. Rev Inst Inv Cienc Salud (Ecuador) 1987;2:5-19.
91. Lopez-Albo W. Cisticercosis del neuro-eje y de las meninges. An Med Int (Madrid) 1932;1:849-78.
92. MacArthur WP. Cysticercosis as a cause of epilepsy in man. Trans R Soc Med Hyg 1933;26:525-8.
93. MacArthur WP. Cysticercosis seen in the British Army with special reference to the production of epilepsy. Trans R Soc Med Hyg 1934;27:343-63.
94. Stepien L, Chorobski J. Cysticercosis cerebri and its operative treatment. Arch Neurol Psychiatry 1949;61:499-527.
95. Dixon HBF, Hargreaves WH. Cysticercosis (T. solium): a further 10 years study covering 284 cases. Q J Med 1944;13:107-21.
96. Dixon HBF, Lipscomb FM. Cysticercosis: an analysis and follow-up of 450 cases. Med Res Council. Spec.rep. no. 299. London: Her Majesty's Stationery Office, 1961:1-58.
97. Lombardo L, Mateos JH. Cerebral cysticercosis in Mexico. Neurology 1961;11:824-8.
98. Lopez-Albo W. Aspectos clinicos de la cisticercosis del sistema nervioso central. Mexico: Multa Pavcis Médica, 1945.
99. Escobar A. Cisticercosis cerebral: estudio de 20 casos. Arch Mex Neurol Psiquiatr 1952;145-67.
100. Bittencourt PRM, Gracia CM, Lorenzana P. Epilepsy and parasitosis of the central nervous system. Recent adv epilepsy. 1988; 4:123-59.
101. Montenegro R, Placencia M, Paredes V, et al. Síndromes cerebro-vasculares asociados a cisticercosis cerebral. Rev Ecuat Neurol 1993;2:104.
102. Alarcón T, Olivares L. Cisticercosis cerebral: manifestaciones clínicas en un medio de alta prevalencia. Rev Invest Clin 1975; 27:209-15.
103. Otero E, Cordova S, Diaz F, García-Teruel I, Del Brutto OH. Acquired epileptic aphasia (the Landau-Kleffner syndrome) due to neurocysticercosis. Epilepsia 1989;30:569-72.
104. Shandera WX, White AC, Chen AC, Diaz P, Armstrong R. Neurocysticercosis in Houston, Texas. Medicine 1994;73:37-52.
105. Bittencourt PRM, Adamolekun B, Bharucha N, et al. Epilepsy in the tropics: I. Epidemiology, socioeconomic risk factors, and etiology. Epilepsia 1996;37:1121-7.
106. Chinchilla N, De Andres C, Roldan SG. Frecuencia de neurocisticercosis en un hospital de Madrid. Arch de Neurobiol 1989;52: 287-94.
107. Earnest MP, Reller LB, Filley CM, Grk AJ. Neurocysticercosis in the United States: 35 cases and a review. Rev Infect Dis 1987;9: 961-76.
108. Martínez SM. Controversias clínicas y terapeúticas en neurocisticercosis. In: Garcia HH, Martínez SM, eds. Teniasis/cisticercosis por T. solium. Lima: Editorial Universo S.A., 1996:207-16.
109. Obrador S. Cysticercosis cerebri. Acta Neurochir 1972;3:320-64.
110. Stepien L. Cerebral cysticercosis in Poland: clinical symptoms and operative results in 132 cases. J Neurosurg 1962;19:505-13.
111. Placencia M, Paredes V, Franco J, et al. Clinical profile of 182 patients with epileptic seizures associated with brain cysticercosis. Epilepsia 1991;32:108-9.
112. Richards FO Jr, Schantz PM, Ruiz-Tiben E, Sorvillo FJ. Cysticercosis in Los Angeles County. JAMA 1985;254:3444-8.
113. Scharf D. Neurocysticercosis: two hundred thirty-eight cases from a California hospital. Arch Neurol 1988;45:777-80.
114. Monteiro L, Almeida-Pinto J, Stocker A, Sampaio-Silva M. Active neurocysticercosis, parenchymal and extraparenchymal: a study of 38 patients. J Neurol 1993;241:15-21.
115. Monteiro L, Nunes B, Mendonaca D, Lopes J. Spectrum of epilepsy in neurocysticercosis: a long-term follow-up of 143 patients. Acta Neurol Scand 1995;92:1,33-40.
116. Forlenza OV, Filho AH, Nobrega JP, et al. Psychiatric manifestations of neurocysticercosis: a study of 38 patients from a neurology clinic in Brazil. J Neurol Neurosurg Psychiatry 1997;62: 612-6.
117. Placencia M, Paredes V, Madera A, Arroyo R, Franco J. La cisticercosis cerebral en epidemiología de epilepsia. Vademecun Farmacéutico, Tercera Edición, Quito: Edifarma, 1993.
118. Nogales-Gaete J, Arriagada C, Gonzáles J. Sindromes anatomoclínicos de la neurocisticercosis. In: Arriagada C, Nogales-Gaete, Apt W, eds. Neurocisticercosis: aspectos epidemiológicos, patológicos, inmunológicos, clínicos, imagenológicos y terapéuticos. Santiago-Chile: Arrynog Ediciones, 1997:117-38.
119. Estañol B, Corona T, Abad P. A prognostic classification of cerebral cysticercosis: therapeutic implications. J Neurol Neurosurg Psychiatry 1986;49:1131-4.
120. Medina MT, Rosas E, Rubio-Donnadieu F, Sotelo J. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 1990;150:325-32.
121. Vázquez V, Sotelo J. The course of seizures after treatment for cerebral cysticercosis. N Engl J Med 1992;327:696-701.
122. Del Brutto OH, Santibañez R, Noboa CA, Aguirre R, Diaz E, Alarcón TA. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992;42:389-92.
123. Hauser WA, Hesdorffer DH. Epilepsy: frequency, causes and consequences. New York: Demos Press, 1990.
124. Comission on Epidemiology and Prognosis of the International League Against Epilepsy. Guidelines for epidemiological studies on epilepsy. Epilepsia 1993;34:592-6.
125. Commission on Epidemiology and Prognosis of the International League Against Epilepsy. The epidemiology of the epilepsies: future directions. Epilepsia 1997;38:614-8.
126. Hauser WA. Recent developments in the epidemiology of epilepsy. Acta Neurol Scand 1995;162:17-21.
127. Sander JWAS, Shorvon SD. Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry 1996;61:433-43.
128. Carpio A, Hauser WA. The distribution and etiology of epilepsy in the tropics of America. Rev Ecuat Neurol 1993;2:137-45.
129. Adamolekun A, Carpio A, Carvalho-Filho F, et al. Relationship between epilepsy and tropical diseases. Epilepsia 1994;35:89-93.
130. Arruda WO. Etiology of epilepsy: a prospective study of 200 cases. Arq Neuropsiquiatr 1991;49:251-4.
131. Bending J, Catford J. Epidemic of burns in New Guinea due to cerebral cysticercosis. Lancet 1983;330:922.
132. Gadjusek DC. Introduction of T. solium in West New Guinea with a note on an epidemic of burns from cysticercus epilepsy in the Ekari people of the Wissel Lakes area. PNG Med J 1978;21:239.
133. Ahuja GK, Mohanta A. Late onset epilepsy. Acta Neurol Scand 1982;66:216-26.
134. Sethi PK, Ku,ar BR, Madan VS, Mohan V. Appearing and disappearing CT scan abnormalities and seizures. J Neurol Neurosurg Psychiatry 1985;48:866-9.
135. Bhatia S, Tandon PN. Solitary "microlesions" in CT: a clinical study and follow-up. Neurol India 1988;36:139-50.
136. Bansal BC, Dua A, Gupta R, Gupta MS. Appearing and disappearing CT scan abnormalities in epilepsy in India: an enigma. J Neurol Neurosurg Psychiatry 1989;52:1185-7.
137. Wadia RS, Makhale CN, Kelkar AN, Grant KB. Focal epilepsy in India with special reference to lesions showing ring or disc like enhancement on contrast computed tomography. J Neurol Neurosurg Psychiatry 1987;50:1298-301.
138. Rajshekhar V, Chacko G, Haran RP, Chandy MJ, Chandi SM. Clinicoradiological and pathological correlations in patients with solitary cysticercus granuloma and epilepsy: focus on presence of the parasite and oedema formation. J Neurol Neurosurg Psychiatry 1995;59:284-6.
139. Wani MA, Benerji AK, Tandom PN, Bhargava S. Neurocysticercosis: some uncommon presentations. Neurol India 1981;29:58-63.
140. Tandom PM, Bhargava S. CNS tuberculosis: lessons learnt from CT studies. Neurol India 1980;28:207-12.
141. Basauri L, Zuleta A, Loayza P, Olivares A. Microabscesses and presumptive inflammatory nodules of the brain. Acta Neurochir 1983;68:27-32.
142. Michael AS, Levy JM, Paige ML. Cysticercosis mimicking brain neoplasm. J Comput Assist Tomogr 1990;14:708-11.
143. Jayakumar PN, Taly AB, Mohan PK. Transient computerized tomographic (CT) abnormalities following partial seizures. Acta Neurol Scand 1985;72:26-9.
144. De Beyl DZ, Hermanus N, Cille H, Goldman S. Focal seizures with reversible hypodensity in the CT scan. J Neurol Neurosurg Psychiatry 1985;48:187.
145. Chandy MJ, Rajshekhar V, Ghosh S, et al. Single small enhancing CT lesions in India patient with epilepsy: clinical, radiological and pathological considerations. J Neurol Neurosurg Psychiatry 1991;54:702-5.
146. Rajshekhar V, Chandy MJ. Validation of diagnostic criteria for solitary cerebral cysticercus granuloma in patients presenting with seizures. Acta Neurol Scand 1997;96:76-81.
147. Ahuja GK, Behari M, Goulatia RK, Jailkhani BL. Disappearing CT lesions in epilepsy: is tuberculosis or cysticercosis the cause? Neurol Neurosurg Psychiatry 1989;52:915-6.
148. Rawlings D, Ferreiro DM, Messing RO. Early CT reevaluation after empiric praziquantel therapy in neurocysticercosis. Neurology 1989;39:739-41.
149. Del Brutto OH. The use of albendazole in patients with single lesions enhanced on contrast CT. N Engl J Med 1993;328:356-7.
150. Rajshekhar V. Albendazole therapy for persistent solitary cysticercus granulomas in patient with seizures. Neurology 1993;43: 1238-40.
151. Padma MV, Behari M, Misra NK, Ahuja NK. Albendazole in single CT ring lesions in epilepsy. Neurology 1994;44:1344-6.
152. Hitchcock ER. Cysticercosis in the UK. J Neurol Neurosurg Psychiatry 1985;50:1080-2.
153. Case records of the Massachusetts General Hospital. Case 20, 1990. N Engl J Med 1990;322:1446-58.
154. Case records of the Massachusetts General Hospital. Case 26, 1994. N Engl J Med 1994;330:188-93.
155. Carpio A. Efecto del tratamiento antiparasitario en la epilepsia secundaria a neurocisticercosis. In: Garcia HH, Martínez S, eds. Teniasis/cisticercosis por T. solium. Lima: Editorial Universo S.A., 1996:193-206.
156. Carpio A, Santillán F, León P, Flores C, Hauser WA. Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med 1995;155:1982-8.
157. Kar AM, Garg RK. Management of small solitary enhancing (ring or disc) CT lesion in patients with epilepsy: does it need change in strategy? Adv Clin Neurosci 1995;5:303-10.
158. Garg RK. Childhood neurocysticercosis: issues in diagnosis and management. Indian Pediatr 1995;32:1023-9.
159. Garg RK, Agrawal A, Medical treatment for cysticercosis. Arch Neurol 1996;53:295.
160. Kramer LD. Medical treatment of cysticercosis: ineffective. Arch Neurol 1995;52:101-2.
161. Kramer LD. Antihelminthic therapy for neurocysticercosis. Arch Neurol 1990;47:1059-60.
162. Salazar M, Gonzáles D. Ensayo terapeútico de la cisticercosis con metrifonato. Rev Inst Salud Pública (Méx) 1972;32:1.
163. Velasco-Suárez M. Medical treatment of neurocysticercosis. In: Palacios E, Rodriguez-Carbajal J, Taveras JM, eds. Cysticercosis of central nervous system. Springfield, IL: Charles C Thomas, 1983:149-54.
164. Tellez-Giron E, Ramos MC, Montante M. The effect of fluobendazole against cysticercus cellulosae in pig. San Luis Potosí: University of San Luis, Department of Biochemistry, 1980.
165. Robles C, Chavarría M. Presentación de un caso clínico de cisticercosis cerebral tratado médicamente con un nuevo fármaco: praziquantel. Salud Pública Mex 1979;21:603-18.
166. Xiao ZX, Zhao CY, Liu LP. Albendazole treatment in cerebral cysticercosis. Chin J Int Med 1986;25:100-2.
167. Alarcón F, Escalante L, Dueńas G, et al. Neurocysticercosis: short course of treatment with albendazole. Arch Neurol 1989;46: 1231-6.
168. Escobedo F, Penagos P, Rodríguez J, Sotelo J. Albendazole therapy for neurocysticercosis. Arch Intern Med 1987;147:738-41.
169. Sotelo J, Escobedo F, Rodriguez-Carbajal J, Torres B, Rubio-Donnadieu F. Therapy of parenchymal brain cysticercosis with praziquantel. N Engl J Med 1984;310:1001-7.
170. Takayanagui OM, Jardim E. Therapy for neurocysticercosis: comparison between albendazole and praziquantel. Arch Neurol 1992;49:290-4.
171. Van Dellen JR, McKeown CP. Praziquantel in active cerebral cysticercosis. Neurosurgery 1988;22:92-5.
172. Botero D, Tanowitz HB, Weiss LM, Wittner M. Taeniasis and cysticercosis. Parasit Dis 1993;7:683-97.
173. Cruz M, Cruz I, Horton J. Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation. Trans R Soc Trop Med Hyg 1991;85:244-7.
174. Robles C, Sedano AM, Vargas-Tentori N, Galindo-Virgen S. Long-term results of praziquantel therapy in neurocysticercosis. J Neurosurg 1987;66:359-63.
175. Proano JV, Madrazo I, Garcia L, Garcia E, Corea D. Albendazol and praziquantel treatment in neurocysticercosis of the fourth ventricle. J Neurosurg 1997;87:29-33.
176. Garcia HH, Gilman RH, Horton J, et al. Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment: Cysticercosis Working Group in Peru. Neurology 1997;48:1421-7.
177. Salinas R, Garner P. Neurocysticercosis. Arch Neurol 1996;53: 213.
178. Garcia HH, Gilman R. Medical treatment of cysticercosis: ineffective vs. effective. Arch Neurol 1996;52:941.
179. Garg RK, Kar AM, Jain S. Failure of albendazole therapy in two common types of parenchymal neurocysticercosis. J Assoc Physicians India 1995;43:706-7.
180. Hachinski VC, Medical treatment of cysticercosis. Arch Neurol 1995;52:104.
181. Moodley M, Moosa A. Treatment of neurocysticercosis: is praziquantel the new hope? Lancet 1989;1:262-3.
182. White AC. Neurocysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis 1997;24:101-15.
183. Caplan LR, Estanol B, Mitchel WG, Loyo-Varela M. How to manage patients with neurocysticercosis. Eur Neurol 1997;37: 124-31.
184. Loyo-Varela M. How to manage patients with neurocysticercosis: surgical treatment of cerebral cysticercosis. Eur Neurol 1997;37: 129-30.
185. Estanol B. How to manage patients with neurocysticercosis: medical treatment of cerebral cysticercosis. Eur Neurol 1997;37: 125-6.
186. Medina MT, Genton P, Montoya MC, et al. Effect of anticysticercal treatment on the prognosis of epilepsy in neurocysticercosis: a pilot trial. Epilepsia 1993;34:1024-7.
187. Del Brutto OH. Prognostic factors for seizures recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology 1994;44:1706-9.
188. Rolfs A, Mühlschlegel F, Jansen-Rosseck R, et al. Clinical and immunologic follow-up study of patients with neurocysticercosis after treatment with praziquantel. Neurology 1995;45:532-8.
189. Manreza ML. Neurocysticercosis in children. In: Fejerman N, Chamoles NAN, eds. Trends in pediatric neurology. Amsterdam: Elsevier Science Publishers B.V, 1993:295-8.
190. Antoniuk SA, Bruck I, Wittig E, Accorsi A. Neurocisticercose na infancia. Arq Neuropsiquiatr (Sao Paulo) 1991;49:47-51.
191. Rosenfeld EA, Byrd SE, Shulman ST. Neurocysticercosis among children in Chicago. Clin Infect Dis 1996;23:262-8.
192. Annerges JF, Hauser WA, Elveback LR. Remission of seizures and relapse in patients with epilepsy. Epilepsia 1979;20:729-37.
193. Hauser WA, Anderson E, Loewenson RB, McRoberts SM. Seizure recurrence after a first unprovoked seizure. N Engl J Med 1982;307:522-8.
194. Elwes RDC, Johson AL, Shorvon SD, Reynolds EH. The prognosis for seizure disorders in newly diagnosed epilepsy. N Engl J Med 1984;311:944-7.
195. Hauser WA, Rich SS, Annerges JF, Anderson VF. Seizure recurrence after a first unprovoked seizure: an extended follow-up. Neurology 1990;40:1163-70.
196. Shinnar S, Berg AT, Moshé SL, et al. Risk of seizure recurrence following a first unprovoked seizure in childhood: a prospective study. Pediatrics 1990;85:1076-85.
197. Cockerell OC, Johnson AL, Sander JWAS, Shorvon SD. Prognosis of epilepsy: a review and further analysis of the first nine years of British National General Practice Study of Epilepsy, a prospective population-based study. Epilepsia 1997;38:47-55.
198. Shinnar S, Vining EP, Mellitis ED, et al. Discontinuing antiepileptic medication in children with epilepsy after two years without seizures: a prospective study. N Engl J Med 1985;313:976-80.
199. Berg AT, Shinnar S. Relapse following discontinuation of antiepileptic drugs: a meta-analysis. Neurology 1994;44:601-8.
200. Gracia FJ, Loo S, Castillo Luis, et al. Epidemiology of epilepsy in Guaymi Indians from Bocas del Toro province, Republic of Panama. Epilepsia 1990;31:718-23.
201. Mitchel WG. How to manage patients with neurocysticercosis: pediatric neurocysticercosis in North America. Eur Neurol 1997; 37:126-9.